Tag
Tag: Genmab
European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm
Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs
Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster
The 8 Best Biotech Companies in Europe’s History
Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Multiple Myeloma Antibody Therapy Achieves Positive Phase III Results
The Billion-Euro European Biotech Companies in 2018
More News! Liquid Biopsy, CAR-T Therapies, and a Failed Lupus Trial…
Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?
Novartis Takes Genmab’s Leukemia Drug Off the Market
